Dr. Kathleen Sakamoto, MD
Palo Alto, CA
34 Years of Experience
Affiliated with a Castle Connolly Top Hospital
Who is Dr. Sakamoto, Pediatric Hematologist-Oncologist in Palo Alto, CA?
Dr. Kathleen Sakamoto, MD is a Pediatric Hematologist-Oncologist, who primarily practices in Palo Alto, CA with 1 additional practice location. She has been practicing for over 34 years and is board certified by the American Board of Pediatrics. Dr. Sakamoto is fluent in English and Spanish, and is currently seeing new patients. Dr. Sakamoto’s practice accepts Kaiser Permanente, Medicare, UnitedHealthcare, Aetna, Cigna and other major insurance plans. To book an appointment or to confirm insurance options, please call Dr. Sakamoto’s office at (310) 206-3952.
What are Areas of Expertise for Dr. Sakamoto?
Dr. Kathleen Sakamoto, MD is a highly-rated, board-certified Pediatric Hematologist-Oncologist known for expertly diagnosing, treating, and managing a wide array of related conditions or procedures. Utilizing the latest medical advancements and evidence-based practices, Dr. Sakamoto empowers patients to confidently navigate their health journey, specializing in Bone Marrow Transplant, Leukemia, Pediatric Cancers, or comprehensive wellness support. Serving the Palo Alto/CA community, Dr. Sakamoto is dedicated to enhancing lives through expert, patient-centered care.
Where did Dr. Sakamoto go to medical school and complete their residency?
Is Dr. Sakamoto board certified in Pediatric Hematologist-Oncologist?
Yes, Dr. Kathleen Sakamoto, MD is board certified by the American Board of Pediatrics
What languages does Dr. Sakamoto speak?
Dr. Sakamoto and their clinical team can communicate with patients in the following languages:
English
Spanish
What conditions does Dr. Sakamoto treat?
As a Pediatric Hematologist-Oncologist, Dr. Sakamoto diagnoses, treats, and manages a wide range of conditions. This condition information is derived from anonymized insurance claims and highlights the medical conditions most commonly treated by Dr. Sakamoto. It provides insight into the doctor’s areas of experience and expertise based on real-world patient encounters from the past two years, updated quarterly.
Also known as:
- Acute Lymphoblastic Leukemia
- Acute Lymphocytic Leukemia in Remission
- Chronic Myeloid Leukemia
- Acute Myeloid Leukemia
- Acute Myeloid Leukemia in Remission
- Leukemia
- Acute Leukemia
- Acute Leukemia in Remission
- Acute Lymphocytic Leukemia
- Chronic Myelogenous Leukemia Treatment (PDQ®)
- ALL
- Acute lymphocytic leukemia
- Lymphoblastic leukemia
- ALL Leukemia in Remission
- Acute Lymphoblastic Leukemia in Remission
- Childhood Leukemia in Remission
- CML
- Chronic myelogenous leukemia
- Philadelphia chromosome positive leukemia
- AML Leukemia
- Acute Myeloblastic Leukemia
- Acute Myelogenous Leukemia
- AML Leukemia in Remission
- Acute Myeloblastic Leukemia in Remission
- Acute Myelogenous Leukemia in Remission
- Blood Cancer
- Cancer of White Blood Cells
- Leukemia types
- Acute Blood Cancer
- Undifferentiated Acute Leukemia
- Fast-growing Blood Cancer
- Acute Blood Cancer in remission
- Leukemia remission
- Acute Lymphocytic Leukemia remission
ICD-10 Codes:
- C9100: Acute lymphoblastic leukemia not having achieved remission
- C9101: Acute lymphoblastic leukemia, in remission
- C9210: Chronic myeloid leukemia, BCR/ABL-positive, not having achieved remission
- C9200: Acute myeloblastic leukemia, not having achieved remission
- C9201: Acute myeloblastic leukemia, in remission
- C9590: Leukemia, unspecified not having achieved remission
- C9500: Acute leukemia of unspecified cell type not having achieved remission
- C9501: Acute leukemia of unspecified cell type, in remission
Also known as:
- Cancer Chemotherapy
- Cancer Immunotherapy
- Chemo treatment
- Oncology chemotherapy
- Cancer drug therapy
- Oncology immunotherapy
- Immune therapy for cancer
ICD-10 Codes:
- Z5111: Encounter for antineoplastic chemotherapy
- Z5112: Encounter for antineoplastic immunotherapy
Also known as:
- Lymphoblastic Lymphoma
- Lymphoma
- LL
- Precursor Lymphoblastic Lymphoma
- Lymphoblastic Lymphoma Cancer
ICD-10 Codes:
- C8350: Lymphoblastic (diffuse) lymphoma, unspecified site
Also known as:
- Widespread Swollen Lymph Nodes
- Localized Swollen Lymph Nodes
- Generalized lymphadenopathy
- Multiple swollen glands
- Body-wide enlarged lymph nodes
- Enlarged glands in one area
- Local lymphadenopathy
- Swollen glands
ICD-10 Codes:
- R591: Generalized enlarged lymph nodes
- R590: Localized enlarged lymph nodes
Also known as:
- Birth Defects Causing Overgrowth
- Birth Defects
- Overgrowth Syndromes
- Congenital Gigantism
ICD-10 Codes:
- Q873: Congenital malformation syndromes involving early overgrowth
Also known as:
- Cancer Follow-up Exam
- Cancer
- Post-cancer treatment checkup
- Malignancy surveillance
- Oncology follow-up
ICD-10 Codes:
- Z08: Encounter for follow-up examination after completed treatment for malignant neoplasm
Also known as:
- Soft Tissue Tumor of Uncertain Behavior
- Connective Tissue Disorder
- Connective Tissue Neoplasm
- Soft Tissue Growth
- Uncertain Soft Tissue Mass
ICD-10 Codes:
- D481: Neoplasm of uncertain behavior of connective and other soft tissue
Also known as:
- Other Types of Pancytopenia
- Blood Disorder
- Rare pancytopenia
- Uncommon low blood counts
- Bone marrow failure
ICD-10 Codes:
- D61818: Other pancytopenia
Also known as:
- Bone Cancer
- Cancer
- Primary Bone Cancer
- Malignant Bone Tumor
- Bone Sarcoma
- Osteosarcoma
ICD-10 Codes:
- C419: Malignant neoplasm of bone and articular cartilage, unspecified
Also known as:
- Hodgkin Lymphoma
- Hodgkin's Disease', 'Hodgkin's Lymphoma
ICD-10 Codes:
- C8190: Hodgkin lymphoma, unspecified, unspecified site
Also known as:
- Soft Tissue Sarcoma
- Cancer
- Connective Tissue Disorder
- Malignant Soft Tissue Tumor
- Connective Tissue Cancer
- Soft Tissue Cancer
ICD-10 Codes:
- C499: Malignant neoplasm of connective and soft tissue, unspecified
Which procedures does Dr. Sakamoto perform as a Pediatric Hematologist-Oncologist?
As a Pediatric Hematologist-Oncologist, procedures performed by a Dr. Kathleen Sakamoto may include:
- 3D Conformal Radiotherapy
- Adaptive Radiation Therapy (ART)
- Adrenalectomy
- Blood Thinning Therapy / Anticoagulation
- Blood Transfusion Consultation
- Blood Transfusion Follow Up
- Bone Excision
- Bone Grafting
For detailed information, please contact Dr. Sakamoto's office.
Does Dr. Sakamoto accept my insurance?
Dr. Sakamoto accepts most major insurance plans. Important: Please call our office at (310) 206-3952 before your appointment to verify that your specific plan and network are accepted.
What insurance plans does Dr. Sakamoto accept in Palo Alto, CA?
Dr. Sakamoto in Palo Alto, CA accepts plans from many carriers. While this list is updated regularly, it is not a guarantee of coverage.
Top Insurances
All Other Third Party
Blue Shield of California
California Water Service Group
Central California Alliance for Health
CVS Health (formerly Aetna)
Express Scripts
Health Plan of San Mateo
Hill Physicians Medical Group
OptumRx
UnitedHealthcare
View All Insurances
Where is Dr. Sakamoto's office located?
Recognitions
Awards
Standing Member, NIDDK-D Study Section for Training Grants and K award
Pediatric Cancer Research Foundation
Gift of Hope Award
Southern California Super Doctors
Top Women Southern California Super Doctors
Southern California Super Doctors 2008
Los Angeles Super Doctors
Chair, Myeloid Biology Subcommittee, American Society of Hematology
Brett Ely Visiting Professor in Pediatric Oncology,
University of Colorado and Children's Hospital Denver
Mendiburu Magic Foundation
Outstanding advances in cancer research award
Fernbach Distinguished Visiting Professor Lectureship, Texas Children
Western Society for Pediatric Research
Junior Faculty Ross Research Award
American Society of Pediatric Hematology/Oncology
Young Investigator Award
UCLA Jonsson Comprehensive Cancer Center
STOP Cancer Career Development award
Children's Hospital of Los Angeles
Victor E. Stork Award
Publications
The Multitargeted Receptor Tyrosine Kise Inhibitor Linifanib
MOLECULAR CANCER THERAPEUTICS, 2011
CREB and leukemogenesis.
Critical reviews in oncogenesis, 2011
Ribosomal protein S19 deficiency in zebrafish leads to developmental abnormalities
BLOOD, 2008
The role of CREB as a proto-oncogene in hematopoiesis and in acute myeloid leukemia
CANCER CELL, 2005
Ubistatins inhibit proteasome-dependent degradation by binding the ubiquitin chain
SCIENCE, 2004
Development of protacs to target cancer-promoting proteins for ubiquitition and degradation
MOLECULAR & CELLULAR PROTEOMICS, 2003
Protacs: Chimeric molecules that target proteins to the Skp1
PROCEEDINGS OF THE TIOL ACADEMY OF SCIENCES OF THE UNITED STATES OF AM, 2001
Net1 stimulates R polymerase I transcription
MOLECULAR CELL, 2001
MicroR-34b promoter hypermethylation induces CREB overexpression
Haematologica, 2013
Increased Abscess Formation and Defective Chemokine Regulation in CREB Transgenic Mice
PLOS ONE, 2013
Identification of somatic
BMC CANCER, 2013
Sox4 cooperates with CREB in myeloid transformation
BLOOD, 2012
The neutropenic diet... still ageless?
Oncology (Williston Park, N.Y.), 2012
Editorial: Granulopoiesis versus monopoiesis
JOURL OF LEUKOCYTE BIOLOGY, 2011
Tubacin suppresses proliferation and induces apoptosis of acute lymphoblastic leukemia cells
LEUKEMIA & LYMPHOMA, 2011
Increasing Diversity in Pediatric Hematology/Oncology
PEDIATRIC BLOOD & CANCER, 2011
The Role of HDAC6 in Cancer
JOURL OF BIOMEDICINE AND BIOTECHNOLOGY
Self-Renewal of Acute Lymphocytic Leukemia Cells Is Limited by the Hedgehog Pathway Inhibitors
PLOS ONE, 2010
The Role of the Transcription Factor CREB in Immune Function
JOURL OF IMMUNOLOGY, 2010
Germline CBL mutations cause developmental abnormalities
TURE GENETICS, 2010
Targeting CREB for Cancer Therapy: Friend or Foe
CURRENT CANCER DRUG TARGETS, 2010
Macroautophagy modulates cellular response to proteasome inhibitors in cancer therapy
DRUG RESISTANCE UPDATES, 2010
Targeting steroid hormone receptors for ubiquitition and degradation in breast and prostate cancer
ONCOGENE, 2008
CREB is a critical regulator of normal hematopoiesis and leukemogenesis
BLOOD, 2008
Expression profile of CREB knockdown in myeloid leukemia cells.
BMC cancer, 2008
Expression of cyclic adenosine monophosphate response-element binding protein in acute leukemia
BLOOD, 2002
What is Dr. Sakamoto's NPI number?An National Provider Identifier (NPI) is a unique ID number that identifies doctors and healthcare providers nationwide.
Dr. Sakamoto's National Provider Identifier (NPI) number is 1437268539.
What common questions do patients ask about Dr. Sakamoto?
Here are answers to patients Frequently Asked Questions (FAQ’s) about Dr. Sakamoto
What is Dr. Kathleen Sakamoto's specialty?
Dr. Sakamoto is a Pediatric Hematologist-Oncologist near Palo Alto, CA. A pediatrician trained in the integration of pediatrics, hematology, and oncology, specializing in the recognition and management of blood disorders and cancer in children. This expert provides comprehensive care for conditions such as anemia, bleeding disorders, and various pediatric cancers. Contact Dr. Sakamoto to book an appointment today.
Is this Dr. Kathleen Sakamoto affiliated with a ranked Castle Connolly Top Hospital?
Yes, Dr. Sakamoto is affiliated with Stanford Health Care - Stanford Hospital which is a Castle Connolly Top Hospital. Castle Connolly Top Hospitals are healthcare institutions recognized for their excellence in specific medical procedures and overall patient care. They are identified through a rigorous peer nomination process, evaluating factors like patient outcomes, quality of care, and expertise. The list recognizes hospitals that excel in 20 or more specific medical procedures, representing the top 25% nationwide. Castle Connolly Top Hospitals
Where can I learn more about Pediatric Hematologist-Oncologist?
Explore Pediatric Hematologist-Oncologist with insights from trusted medical experts on EverydayHealth.com, where you'll find the most relevant content and helpful condition guides for up-to date information about symptoms, causes, diagnosis, treatment and more. See all our health guides to find trusted information on medical conditions from our experts at Everyday Health.
Is Kathleen Sakamoto accepting new patients in Palo Alto, CA?
Yes, Dr. Kathleen Sakamoto is accepting new patients at this time.
Does Dr. Kathleen Sakamoto offer online booking?
Please contact Dr. Sakamoto's office at (310) 206-3952 for information about online booking, telehealth, or to schedule an appointment.
How can I make an appointment with Kathleen Sakamoto?
Please contact Dr. Sakamoto's office at (310) 206-3952 for information regarding telehealth appointment availability or for scheduling assistance.
Which board certifications does Dr. Kathleen Sakamoto have?
Dr. Kathleen Sakamoto is certified by the American Board of Pediatrics.
Other Pediatric Hematologist-Oncologist Near Palo Alto, CA
Pediatric Hematologist-Oncologist
Accepting patientsPediatric Hematologist-Oncologist
Accepting patientsPediatric Hematologist-Oncologist
Accepting patients